AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read More

Top Stories

Now Cactus Life Sciences Companies, nspm and eluSCIdate

Cactus Life Sciences Announces the Acquisition

FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...

Cactus Life Sciences Appoints Oliver Dennis to

Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Target, Bull's Eye, Omnichannel Strategy, Success, Efficiency

Optimizing Medical Affairs with Modular Content:

Turn your organization into an “efficiency powerhouse” with...
Target, Bull's Eye, Omnichannel Strategy, Success, Efficiency

Optimizing Medical Affairs with Modular Content: A Journey through Every Step and Stage of Omnichannel Excellence

Turn your organization into an “efficiency powerhouse” with the transformative power of modular content and...
Periodic Safety Update Report (PSUR) - Medical Device

Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21

A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...
reimagining scientific communications

Scientific Communication Strategies for Digital Transformation

Read how digital transformation strategies can help to rethink workflows for future readiness and scale-up...
EU MDR Whitepaper

EU MDR: Increasing Expectations for Clinical Evidence

While the global medical devices industry is closely watching how the European Union (EU) Medical...

Learn more ABOUT our company.